Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study.
about
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapiesTreating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesIL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice.Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockade.A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.Role of biologics in intractable urticaria.Are neutrophilic dermatoses autoinflammatory disorders?Interleukin-1 Blockade: An Update on Emerging Indications.Schnitzler Syndrome: a Review.Clinical characterization and long-term follow-up of Schnitzler syndrome.Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome.Schnitzler syndrome, a rare autoinflammatory disease. Complete response to IL-1 blockade.Molecular genetic investigation, clinical features and response to treatment in 21 patients with Schnitzler's syndrome.Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.Radiotherapy for a breast cancer patient with Schnitzler syndrome: Report of acute toxicity and early follow-up.[Monoclonal gammopathy of undetermined significance and multiple myeloma].Rare diseases and costly treatments: the role of IL-1β in pustular psoriasis.Schnitzler syndrome associated with hairy cell leukemia presenting with chronic urticaria and arthralgias.Different Therapeutic Paths (Colchicine vs. Anakinra) in Two Patients With Schnitzler's Syndrome
P2860
Q26777084-39542B42-2BC5-4530-B9D0-7B151A13B58CQ26799747-AE26379E-34D2-4B05-928E-6B05B566508BQ35681138-67BBD195-D9FA-4463-A3C7-A3D8A2ED7DBBQ36990716-61DEEF00-ACEA-40F2-A0B6-328B49504B62Q37361075-16DBAF43-9F91-4A3E-BA81-BC916251AEB1Q38450662-BF9F0810-6577-4AF2-AD07-3063B6D1D878Q39025288-FAC5912C-8B62-4C65-A768-C4B16446FA3EQ39301613-917BF3CE-3CBB-4708-8F07-040FB61442DCQ39440981-C4DB0E82-6806-4D67-A0AF-B182DA12BF37Q40103586-4E815DA4-2A5B-4DE6-A55E-AD57406F217AQ40118761-A317B4BB-50F2-4698-A6CD-143B1B98A52BQ47136866-83B38333-8F80-46EB-AF93-068B1DC54821Q47248926-F692E5DD-A560-44F4-8E1E-630EECBC7939Q48109341-537669D6-C484-4925-B450-E694B088E01DQ49979072-5D7B58DC-7899-4EB7-8DDB-DC0207F12873Q50057568-8B9AED18-409F-4C45-83FB-32DAA248AC86Q51184652-C22641F3-4116-4175-926B-7E5A6EBB85B8Q55100984-50F4C421-3237-40C3-8605-93F153346568Q58134801-F9B71E96-7B91-420F-870A-5A8E5E08F5AF
P2860
Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Long-term effectiveness and sa ...... e: a French multicenter study.
@en
type
label
Long-term effectiveness and sa ...... e: a French multicenter study.
@en
prefLabel
Long-term effectiveness and sa ...... e: a French multicenter study.
@en
P2093
P50
P1433
P1476
Long-term effectiveness and sa ...... e: a French multicenter study.
@en
P2093
Achille Aouba
Adrien Lorleac'h
Agathe Masseau
Amar Smail
Arnaud Hot
Benoit Henry
Bernard Grosbois
Bérangère Cador
Claire Bernier
Fabienne Closs-Prophette
P304
P356
10.1016/J.AUTREV.2014.08.031
P577
2014-08-23T00:00:00Z